Sanofi to buy Kiadis
The move gives the French drug giant access to Kiadis’ natural killer cell technology platform
Read More
Tag: natural killer cells
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
